Immunoediting, neoantigen frequency, and clinical outcome in patients with ovarian clear cell carcinoma

被引：1
|
作者：
Hasegawa, K. [1 ]
Matsushita, H. [2 ]
Oda, K. [3 ]
Yamamoto, S. [4 ]
Nishijima, A. [3 ]
Imai, Y. [1 ]
Asada, K. [3 ]
Ikeda, Y. [1 ]
Fujiwara, K. [1 ]
Aburatani, H. [4 ]
Kakimi, K. [2 ]
机构：
[1] Saitama Med Univ Int Med Ctr, Hidaka, Japan
[2] Univ Tokyo Hosp, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 145卷
关键词：
D O I：
10.1016/j.ygyno.2017.03.039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页码：7 / 8
页数：3
相关论文
共 50 条
  • [21] Molecular Characterization and Clinical Outcome of Clear Cell Papillary Renal Cell Carcinoma
    Viswanathan, Kartik
    Park, Kyung
    Khani, Francesca
    Mosquera, Juan Miguel
    Robinson, Brian
    MODERN PATHOLOGY, 2018, 31 : 397 - 397
  • [22] Clonal architectures predict clinical outcome in clear cell renal cell carcinoma
    Yi Huang
    Jiayin Wang
    Peilin Jia
    Xiangchun Li
    Guangsheng Pei
    Changxi Wang
    Xiaodong Fang
    Zhongming Zhao
    Zhiming Cai
    Xin Yi
    Song Wu
    Baifeng Zhang
    Nature Communications, 10
  • [23] Clonal architectures predict clinical outcome in clear cell renal cell carcinoma
    Huang, Yi
    Wang, Jiayin
    Jia, Peilin
    Li, Xiangchun
    Pei, Guangsheng
    Wang, Changxi
    Fang, Xiaodong
    Zhao, Zhongming
    Cai, Zhiming
    Yi, Xin
    Wu, Song
    Zhang, Baifeng
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [24] Clear clinical remission of a diffuse metastasized ovarian clear cell carcinoma with third line chemotherapy
    Debois, JM
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (07) : 709 - 712
  • [25] Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
    Zhou, Huimei
    Liu, Qian
    Shi, Xiaohua
    Liu, Yue
    Cao, Dongyan
    Yang, Jiaxin
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [26] A HIGHER PERITONEAL NK CELL FREQUENCY IS RELATED TO BETER OUTCOME IN ADVANCED OVARIAN CARCINOMA PATIENTS
    Hoogstad-van Evert, J.
    Maas, R.
    van der Meer, J.
    Cany, J.
    van der Steen, S.
    Jansen, J.
    Torensma, R.
    Bekkers, R.
    Hobo, W.
    Massuger, L.
    Dolstra, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 189 - 189
  • [27] Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
    Huimei Zhou
    Qian Liu
    Xiaohua Shi
    Yue Liu
    Dongyan Cao
    Jiaxin Yang
    Journal of Ovarian Research, 13
  • [28] PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA ARE AT HIGH RISK OF SECONDARY MALIGNANCY
    Nguyen, J. M. V.
    Vicus, D.
    Bernardini, M. Q.
    Hogen, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A130 - A131
  • [29] Differences in survival between clear cell uterine and ovarian carcinoma patients
    Usach, I.
    Blansit, K.
    Gardner, A. B.
    Kapp, D. S.
    Chen, L. M.
    Ueda, S. M.
    Brooks, R. A.
    Chan, J. K.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 87 - 87
  • [30] CYTOLOGIC FINDINGS OF ASCITES IN PATIENTS WITH OVARIAN CLEAR CELL-CARCINOMA
    NISHIDA, M
    KANEKO, M
    YOSHIDA, T
    ACTA CYTOLOGICA, 1981, 25 (01) : 52 - 52
12345